Sebia
sebia.com
Actively hiring
E-learning
Diagnostic Tests & IVD
Health Care
As featured in
Claim pageClaim
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
News
ABIONYX Pharma and SEBIA Announce an Exclusive Global Strategic Partnership to Transform Sepsis Diagnosis
TOULOUSE, France & FULLERTON, Calif. & LISSES, France, November 20, 2025--Regulatory News: ABIONYX Pharma, (FR0012616852 - ABNX - eligible PEA PME), a next-generation biopharma company pioneering a new therapeutic era in sepsis and critical care through i
Read more
Report
ABIONYX Pharma and SEBIA Announce an Exclusive Global Strategic Partnership to Transform Sepsis Diagnosis
Read more
Report
Warburg Pincus in talks to buy minority stake in Sebia
Existing stakeholders CVC, La Caisse and Téthys Invest to remain significant investors.
Read more
Report
Sebia and Metafora biosystems form Strategic partnership to Develop Advanced In Vitro Diagnostics tests
/PRNewswire/ -- Sebia, a world leader in diagnostics in the fields of multiple myeloma and chronic diseases, and Metafora biosystems ("Metafora") today...
Read more
Report
French Sebia buyout financing launches for syndication
A 709 million euro-equivalent (564 million pounds) covenant-lite financing backing private equity firms Montagu and Astorg's acquisition of French medical diagnostics company Sebia has launched for sy...
Read more
Report
Growth
Hiring Momentum
28/100
Slowing
Open positions
1
0 opened / 0 closed in 30 days
ATS activity
Every ~5 hours
Today
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Field & Service
100% ▲